This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Nicolas Georges Rene Proisy: Innovator in Molybdopterin Precursor Synthesis
Introduction
Nicolas Georges Rene Proisy is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of synthetic chemistry, particularly in the development of methods for synthesizing molybdopterin precursor Z derivatives. His work is crucial for advancing treatments for diseases associated with molybdenum cofactor deficiency.
Latest Patents
Proisy holds a patent for "Methods for synthesizing molybdopterin precursor Z derivatives." This patent outlines synthetic methods for preparing compounds of formula (I) and formula (XIII). The disclosure also includes useful intermediates, derivatives, prodrugs, and pharmaceutically acceptable salts, solvates, and hydrates of these compounds. These innovations are essential for developing therapies for specific medical conditions.
Career Highlights
Throughout his career, Proisy has worked with prominent companies in the pharmaceutical industry, including Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sarl. His experience in these organizations has allowed him to contribute to significant advancements in drug development and synthesis.
Collaborations
Proisy has collaborated with talented individuals in his field, including Xiangtian Long and Danmei Dai. These partnerships have fostered innovation and have been instrumental in the progress of his research.
Conclusion
Nicolas Georges Rene Proisy is a distinguished inventor whose work in synthetic methods for molybdopterin precursor Z derivatives has the potential to impact medical treatments significantly. His contributions to the field of chemistry and collaboration with leading companies and professionals highlight his importance in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
